Your Location:
Home >
Browse articles >
Xianglian Huazhuo Prescription Regulates GP73/PERK/ATF4 Signaling Pathway to Influence Endoplasmic Reticulum Stress and Ameliorate Chronic Atrophic Gastritis
Updated:2026-10-08
    • Xianglian Huazhuo Prescription Regulates GP73/PERK/ATF4 Signaling Pathway to Influence Endoplasmic Reticulum Stress and Ameliorate Chronic Atrophic Gastritis

    • “Xianglian Huazhuo Formula can activate the GP73/PERK/ATF4 signaling pathway to induce endoplasmic reticulum stress, providing a new strategy for the treatment of chronic atrophic gastritis.”
    • DU Pengli , GUO Yuxi , WANG Yican , JIN Ziqi , KANG Xin , JIA Xuemei , XU Weichao , CAI Yanru , YANG Qian
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 21, Pages: 19-28(2026)
    • DOI: 10.13422/j.cnki.syfjx.20260538     

      CLC:
    • Revised:2026-03-06 ,

      Accepted:11 March 2026 ,

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 7 ) Tabs( 5 )

  • Editor's note

  • References

  • Publication Info

  • Metrics

279

Views

46

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Xianglian Huazhuo Prescription Regulates Nrf2/NQO1/HO-1 Signaling Pathway to Affect Oxidative Stress in Treatment of Chronic Atrophic Gastritis
Xianglian Huazhuo Prescription Regulates miR-34b-5p/PFKFB1 Signaling Pathway to Inhibit Glycolysis and Ameliorate Chronic Atrophic Gastritis
Xianglian Huazhuo Prescription Ameliorates Chronic Atrophic Gastritis via Regulating Lysosomal Iron Metabolism
Hezhong Xiaopi Granules Regulate Ncln-CHOP Axis to Inhibit Endoplasmic Reticulum Stress and Reduce Gastric Mucosal Cell Apoptosis
Traditional Chinese Medicine Intervention in Parkinson's Disease Based on Keap1/Nrf2/ARE Signaling Pathway: A Review

Related Author

DU Pengli
GUO Yuxi
KANG Xin
JIA Xuemei
XU Weichao
CAI Yanru
YANG Qian
LI Xiaojing

Related Institution

Hebei Provincial Hospital of Traditional Chinese Medicine
Hebei Key Laboratory of Turbidity Toxin Syndrome
Hebei University of Chinese Medicine
Postdoctoral Research Center, China Academy of Chinese Medical Sciences
Guang'anmen Hospital, China Academy of Chinese Medical Sciences